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Action potential duration restitution and ventricular fibril-
lation due to rapid focal excitation. Am J Physiol Heart Circ
Physiol 282: H1915–H1923, 2002. First published January
24, 2002; 10.1152/ajpheart.00867.2001.—The focal source
hypothesis of ventricular fibrillation (VF) posits that rapid
activation from a focal source, rather than action potential
duration (APD) restitution properties, is responsible for the
maintenance of VF. We injected aconitine (100 g) into nor-
mal isolated perfused swine right ventricles (RVs) stained
with 4-{-[2-(di-n-butylamino)-6-naphthyl]vinyl}pyridinium
(di-4-ANEPPS) for optical mapping studies. Within 97 
163 s, aconitine induced ventricular tachycardia (VT) with a
mean cycle length 268  37 ms, which accelerated before
converting to VF. Drugs that flatten the APD restitution
slope, including diacetyl monoxime (10–20 mM, n  6),
bretylium (10–20 g/ml, n  3), and verapamil (2–4 g/ml,
n  3), reversibly converted VF to VT in all cases. In two RVs,
VF persisted despite of the excision of the aconitine site.
Simulations in two-dimensional cardiac tissue showed that
once VF was initiated, it remained sustained even after the
“aconitine” site was eliminated. In this model of focal source
VF, the VT-to-VF transition occurred due to a wave break
outside the aconitine site, and drugs that flattened the APD
restitution slope converted VF to VT despite continuous ac-
tivation from aconitine site.
arrhythmia; mapping; pacing; tachyarrhythmias
THE MECHANISM OF ventricular fibrillation (VF) is un-
clear. The multiple wavelet hypothesis (13) posits that
dispersion of refractoriness underlies the mechanisms
of wave breaks, resulting in the maintenance of VF.
The dispersion of refractoriness could be caused either
by preexisting electrophysiological or anatomic heter-
ogeneity, or dynamically by steep action potential (AP)
duration (APD) restitution (3, 5, 15, 18, 19, 22). Flat-
tening of the APD restitution curve with verapamil,
diacetyl monoxime (DAM) (19), and bretylium (3) has
been shown to convert VF to a periodic rhythm, or
ventricular tachycardia (VT), in canine and porcine
ventricles. An alternative hypothesis of cardiac fibril-
lation is the focal source hypothesis. A rapidly firing
focal source induced by aconitine (16) or a mother rotor
(4) could drive the entire atria or ventricle into fibril-
lation. The period of the mother rotor determines the
dominant frequency (DF) of cardiac fibrillation. Samie
et al. (20) tested the mother rotor hypothesis in rabbit
ventricles. They also found that verapamil converted
VF to VT, but attributed this to the effect of verapamil
on the core size and the period of mother rotor rather
than APD restitution. However, because verapamil
also flattens APD restitution (19), it is not possible to
completely rule out that the antifibrillatory action of
verapamil is due to its effects on APD restitution. To
resolve this issue, it is necessary to develop an animal
model in which VF is caused by rapid focal discharge
from a fixed and known location. If drugs that flatten
APD restitution convert VF to VT independent of
the period of the focal source in this model, then the
importance of restitution can be ascertained. For elec-
trical stimulation to achieve 1:1 capture at a period of
a rotor (10 Hz) (20), it usually requires a strong
stimulus strength that might exceed 10 mA (1, 6).
Because it is unlikely for a mother rotor to generate a
10-mA current, we propose that rapid pacing is not an
appropriate model to test the focal source hypothesis of
VF. Aconitine, a sodium channel opener that is known
to cause focal atrial fibrillation (16), may result in
rapid focal discharge from the myocardium at rate
approaching 10 Hz. Therefore, we first examined
whether direct aconitine injection into the swine right
ventricle (RV) would mimic focal source VF. We then
studied the effects of verapamil, DAM, and bretylium,
which, although they have divergent effects on rotor
period and VF cycle length (CL), all flatten the APD
restitution.
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METHODS
Tissue preparation. The animal research protocol was ap-
proved by the Institutional Animal Care and Use Committee
and conformed to the guidelines of the American Heart As-
sociation. Eleven farm pigs (25–35 kg wt) of either sex were
anesthetized with pentobarbital sodium (20 mg/kg iv). The
RVs were isolated and perfused through the right coronary
artery with oxygenated Tyrode’s solution at 37°C (7). The
composition of Tyrode’s solution (in mmol/l) was as follows:
125 NaCl, 4.5 KCl, 1.8 NaH2PO4, 24 NaHCO3, 2.7 CaCl2, 0.5
MgCl2, and 5.5 dextrose (8). The RVs were placed with the
endocardial side down in a tissue bath. VF, which always
occurred during heart excision, continued in isolated RVs.
After baseline recordings, the tissue was defibrillated and
paced at fixed CL of 400 ms with twice the diastolic threshold
current and 5-ms pulse width through a bipolar electrode on
the epicardial surface.
Pseudo-electrocardiograms (ECG) were recorded via two
electrodes on opposing sides of the RV (7). Bipolar electrode
pairs were placed at the aconitine injection site and at a site
distant from that area.
Optical mapping. The methods of optical mapping was
similar to that published previously (10, 21). The isolated
RVs were stained for 20 min with the voltage-sensitive dye
4-{-[2-(di-n-butylamino)-6-naphthyl]vinyl}pyridinium (di-4-
ANEPPS) (Molecular Probes) in the perfusate and excited
with a laser at 532 nm. Light was collected using an image-
intensified charge-coupled device camera (Dalsa). The data
were gathered at a 2.3-ms sampling interval, acquiring from
128  128 sites simultaneously over a 3  3-cm2 area. The
duration of each recording was 2.3 s. Data for each pixel were
represented on a gray scale, with white representing fully
depolarized and black representing fully repolarized states,
respectively. Depolarization wave fronts are shown by red
lines and repolarization wave backs are shown by blue lines,
with their junctions representing wave breaks.
We also manually determined the APD restitution curves
by using optical signals recorded during VT, VT-to-VF tran-
sition, and VF. On each tracing, a horizontal line was drawn
at one-sixth of the maximum AP amplitude from the base-
line. The intersection between this line and the upslope of the
AP is the time of depolarization, and the intersection be-
tween this line and the downslope of the AP is the time of
repolarization. The APD and depolarization interval (DI)
were defined as the time interval between depolarization and
repolarization and between repolarization and depolariza-
tion, respectively. The relationship between the APD and the
preceding DI was plotted and the APD restitution slopes
were calculated by single-exponential fits to the data.
Study protocol. Aconitine (100 g) was injected locally at
the center of the RV, inducing VT and VF. After data acqui-
sition, 10–20 mM DAM (n  6) (19) was infused to convert
VF back to VT and then washed out to convert VT back to VF.
In three more RVs, we first infused and then washed out
bretylium (10–20 G/ml) (n  3) (3), followed by 2–4 G/ml
verapamil (20) infusion and washout. In one of these three
RVs, bretylium was reinfused a second time, followed by
reinjection of aconitine and infusion of verapamil with bre-
tylium still present. In two additional RVs, we excised the
aconitine site to determine whether VF persisted. Other than
DAM and verapamil, we did not use electromechanical un-
couplers in the study.
DF analysis. Fast Fourier transform (FFT) was applied to
the optical signals at each pixel (1,000 data points for 2.3-s
recording) and to the pseudo-ECG and bipolar recordings
near and far from aconitine site (50,000 data points for 10-s
recording). The frequency corresponding to the largest spec-
tral peak was defined as the DF. The value of DF of each pixel
was used to generate an iso-DF map.
Statistical analyses. Student’s t-tests were used for statis-
tical comparison. P  0.05 was considered significant. Anal-
ysis of variance with Dunn’s (Bonferroni) correction was used
to compare the means of three groups. All data are presented
as means  SD.
Computer simulation. Numerical simulations were carried
out using the following cable equation (17)
Cm
V
t
  Iion
1
xSv
2V
x2

1
ySv
2V
y2
(1)
where the membrane capacitance Cm  1 F/cm2, the sur-
face-to-volume ratio Sv  2,000 cm	1, the transverse and
longitudinal resistivities x  y  0.5 k
 cm, V is voltage,
and t is time. We simulated a 10  10-cm tissue with
“no-flux” boundary conditions. In Eq. 1, the ionic current Iion
was taken from the Luo-Rudy AP model (12), modified to
change AP restitution properties, as specified in the figure
legends. We introduced heterogeneity into the tissue by two
methods. In the first, we changed the maximum potassium
channel conductance (G K) through space as follows
G Kx, y  G K, if x  5 cm x 5G K, if 5 cm  x  6 cm
 G K if x  6 cm
(2)
where G K  0.282 mS/cm2 and  and  are constants that
control the inhomogeneity. In the second, we changed the
maximum potassium channel conductance as follows
G Kx, y  r 1G K if r  1 cmG K, otherwise (3)
where r is the distance from the aconitine site. We mimicked
aconitine-induced automaticity by pacing the tissue at a
small area whenever the diastolic interval exceeded a critical
(adjustable) value. A pseudo-ECG was constructed by sum-
ming membrane voltage, as described previously (23).
RESULTS
Induction of VT and VF by aconitine. In all RV
tissues, local injection of aconitine (100 g) induced VT
within 97  162 s. The initial CL was 268  37 ms,
which progressively decreased to 156  40 ms before
deteriorating to VF. Time from VT induction to VF
averaged 377  657 s. Figure 1 shows a typical exam-
ple. Twenty-five seconds after aconitine injection, the
first beat of VT occurred, and pacing was turned off.
Figure 1B shows a 3-s recording at the onset of VT. The
first four beats were paced at a CL of 400 ms and the
fifth beat (arrow) occurred before the pacing stimulus.
This fifth beat was therefore the first beat of VT with
an initial CL of 300 ms. At time 50 s (Fig. 1C), the VT
CL decreased to 150 ms. At time 76 s (Fig. 1D), the
pseudo-ECG recording and the bipolar recording dis-
tant from the aconitine site showed VF. However, the
aconitine site was still activated at a regular CL of 125
ms. At time 86 s (Fig. 1E), the aconitine injection site
also demonstrated VF. Optical mapping during aconi-
tine-induced VT (Fig. 2A) revealed focal activation
originating from the aconitine injection site (yellow
arrowhead) at 244-ms CL. The wave front first spread
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along the fiber orientation and then to the rest of the
tissue, giving rise to the periodic optical potential re-
cordings.
In two episodes, we successfully mapped the transi-
tion of VT to VF. Figure 2 shows a 2.3-s recording
containing the VT-to-VF transition. The transition oc-
curred when wave breaks were created (Fig. 2A,
442-ms panel). Once established, VF was characterized
by clockwise and counterclockwise rotating spiral
waves, multiple wave breaks, and multiple irregular
Fig. 1. Example of the aconitine-in-
duced ventricular tachycardia (VT)-
to-ventricular fibrillation (VF) ratio
(VT to VF). Pseudoelectrocardiogram
(ECG) was recorded from electrodes
placed on opposite ends of the right
ventricle (RV). Time of aconitine injec-
tion is time 0. A: tissue was constantly
paced at a 400-ms cycle length (CL)
until the induction of VT. B: 25 s after
injection, VT occurred (arrow) at an
initial CL of 300 ms. C: 50 s after
injection, the VT CL decreased to 150
ms. D: conversion of VT to VF (arrow)
at time 76 s. E: activations registered
during VF 90 s after aconitine injec-
tion.
Fig. 2. Aconitine-induced VT-to-VF transition. A: 2.3-s recording containing the VT-to-VF transition. The first 6
photos show VT activation. The pattern was characterized by focal activation arising from the aconitine site
(arrowhead). The activation first spread along the fiber orientation and then activates the rest tissue. The next 6
photos show a wave break (at 442 ms), followed by clockwise rotating reentrant excitation wave. B: fast Fourier
transform (FFT) analysis of optical signals at the aconitine site over the full 2.3-s segment revealed two peaks with
frequencies of 9.6 and 11.9 Hz. When the FFT analysis was applied to the VT segment alone, only the 9.6-Hz
frequency was observed, whereas for the VF segment, only the 11.9-Hz frequency was present. C: the isodominant
frequency (DF) map shows the distribution of DF, with white color indicating the highest DF and black color
indicating the lowest DF. The highest DF in this episode appeared at the aconitine injection site. D: shows iso-DF
map after excision of aconitine site. More than one region showed high DF.
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wave fronts. In Fig. 2B, FFT analysis of optical signals
at the aconitine site over the full 2.3-s segment re-
vealed two peaks with frequencies of 9.6 and 11.9 Hz.
When the FFT analysis was applied to the VT segment
alone, only the 9.6-Hz frequency was observed,
whereas for the VF segment, only the 11.9-Hz fre-
quency was present. This finding indicates that the
frequency changed abruptly at the aconitine site when
VF occurred. This was not due to a sudden increase in
the automatic focus CL at the aconitine site, because
aconitine-induced automaticity accelerated gradually,
never abruptly. In addition, the spatial distribution of
the DF in the FFT spectra for the whole 2.3-s episode
(Fig. 2C) illustrates that the low and high frequency
originated from different areas and that the maximal
frequency was in the aconitine area (11.89 Hz). After
the aconitine site was ablated, the maximum DF dur-
ing VF might not be close to the ablated site (Fig. 2D).
Restitution during VT, VT-to-VF transition, and VF.
An example of optical recording of aconitine-induced
VT during VT-to-VF transition and during VF are
given in Fig. 3A. The APD restitution curves of these
three different phases are shown in Fig. 3B. The max-
imal slopes of the APD restitution curves were 0.226,
3.3, and 1.76 for VT, VT-to-VF transition, and VF,
respectively.
Conversion of VF to VT by flattening restitution.
DAM (6 of 6), bretylium (3 of 3), and verapamil (3 of 3)
all converted aconitine-induced VF to VT (Fig. 4). The
VT rates after conversion were 9.7, 7.3, and 14.1 Hz,
respectively (P  0.01). The time intervals between
drug infusion and conversion of VF to VT were 12.3 
5.1, 13  5.2, and 24.3  4.0 min, respectively. Vera-
pamil conversion time was significantly longer com-
pared with DAM and bretylium (P  0.05).
All drug effects were reversible on washout, with VT
converting back to VF within 8.5  3.0, 6.3  0.3, and
11.7  1.5 min for DAM, bretylium, and verapamil,
respectively (P  not significant). Figure 4 also shows
typical examples. In these examples, DF did not
change significantly with DAM or bretylium (Table 1).
In contrast, DF increased significantly with verapamil
(P  0.01).
Table 1 summarizes DF at different stages of the
experiments. When the baseline aconitine-induced VF
of all nine RVs were pooled, the DF at the aconitine
injection site was significantly higher than the DF
registered by the pseudo-ECG (10.1  1.6 vs. 8.1  1.6
Hz, respectively, P  0.05). In all RVs, the maximal DF
of the entire RV was located at the aconitine site. These
results suggest that the aconitine site is a fixed and
known origin for rapid focal activation during VF.
Thus, despite their very different electrophysiologi-
cal profiles, all three APD restitution-flattening drugs
converted VF to VT, with no clear relationship between
their effects on DF and their ability to convert VF.
Fibrillatory conduction block and maintenance of
aconitine-induced VF. We then examined whether VF
could be maintained by passive fibrillatory conduction
block driven by the aconitine site as the only mecha-
nism of new wave break. In one RV, we gave bretylium
to convert VF to VT and then reinjected the aconitine
site with fresh aconitine (Fig. 5). With conversion to VT
by bretylium, DF decreased to 6.6 Hz. Reinjection of
aconitine then increased DF at the aconitine site to
15.8 Hz, causing 2:1 conduction block (7.9 Hz) at dis-
tance sites. The pseudo-ECG and optical traces contin-
ued to show VT under these conditions, and electrocar-
diographic VF never occurred. The addition of
verapamil to shorten refractoriness (while retaining
flat APD restitution) allowed the resumption of 1:1
conduction at the high frequency (14.6 Hz) of the ac-
onitine site, with the electrogram still showing VT but
at a faster rate. Thus, with flat APD restitution, the
rapid focal discharge (VT) did not undergo fibrillatory
conduction and no VF was induced.
In two RVs, we excised the aconitine site after VT-
to-VF transition had occurred. DF on the pseudo-ECG
before and after excision were the same, and VF per-
sisted for 15 min. These findings are similar to those
Fig. 3. Action potential duration (APD)
restitution during, before and after VT-
to-VF transition. A: representative op-
tical recordings of aconitine-induced
VT, VT-to-VF transition, and VF in the
same RV. Note that there was a slight
variation of VT CL (128–122 ms). APD
ranged between 103 and 110 ms and the
depolarization interval (DI) ranged be-
tween 16 and 29 ms. B: APD restitution
curves during VT (), VT-to-VF transi-
tion (), and VF (F). The maximal slope
of APD restitution curves for VT, VT to
VF, and VF were 0.226, 3.3, and 1.76,
respectively. APD90, APD at 90% repo-
larization.
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found in aconitine-induced atrial fibrillation. Once in-
duced, the atrial fibrillation is also independent of the
aconitine focus (14).
Computer simulations. To gain further insight into
the role of APD restitution in focal source VF, we
performed computer simulations using a modified ver-
sion of the Luo-Rudy phase 1 ventricular AP model in
simulated two-dimensional cardiac tissue incorporat-
ing a physiological degree of APD dispersion (see METH-
ODS). We stimulated the effects of aconitine by pacing a
small region (the “aconitine focus”) in the center of the
tissue (site 2 of Fig. 6A) whenever the diastolic interval
exceeded a critical (adjustable) duration. Under control
conditions, in which the APD restitution slope was
steep enough (1) to produce spontaneous spiral wave
breakup, increasing the frequency of the aconitine fo-
cus 9 Hz led to a distant wave break, which initiated
“VF” (Fig. 6D). At this point, a second higher-frequency
component at 10.8 Hz appeared due to penetration of
the aconitine focus by outside reentrant wave fronts
(Fig. 6B), reproducing the experimental observations
in Fig. 2B. As in Fig. 2B, the FFT spectra for the
transition from VT to VF shows two peaks, at 9.1 and
10.4 Hz. The first is attributable exclusively to the VT
Fig. 4. DF analysis of the ECG recordings obtained during various phases of the study. Left to right: recordings
associated with diacetyl monoxime (DAM), bretylium, and verapamil experiments, respectively. A vertical line was
drawn through the DF of baseline VF. There was no change of DF with DAM, a small but insignifcant reduction
of DF with bretylium, and significant increase of DF with verapamil. See text for details.
Table 1. Dominant frequency analysis
Group n
Aconitine-
Induced VF, Hz
6 Min of
Drug Perfusion, Hz
VF-to-VT
Conversion, Hz
VF After
Washout, Hz P
DAM 6
Pseudo-ECG 8.11.6 9.41.4 9.71.2 10.90.4 Hz NS
Aconitine site 10.11.8 10.31.4 9.71.2 11.10.4 Hz NS
Bretylium 3
Pseudo-ECG 7.52.2 7.60.4 7.30.2 8.30.9 NS
Aconitine site 8.81.6 7.60.4 7.30.2 8.20.9 NS
Verapamil 3
Pseudo-ECG 8.20.91 15.41.02 15.30.83 14.40.54 0.01*
Aconitine site 8.20.91 14.80.72 14.01.23 14.40.64 0.01*
Values are means  SD; n, no. of pigs. VF, ventricular fibrillation; DAM, diacetyl monoxime; ECG, electrocardiogram; NS, not significant;
VT, ventricular tachycardia. *Comparing 1 with 2, 3, and 4.
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phase immediately before VF, and the second is exclu-
sively to the VF phase, as shown by the individual FFT
spectra for the two phases. Figure 6C shows that the
FFT spectra were qualitatively very similar to the FFT
spectra for real data (Fig. 4). VF was self-sustaining
and not dependent on the aconitine focus under these
conditions because VF continued indefinitely when the
focus was turned off.
If APD restitution slope in the Luo-Rudy phase 1
model was flattened to 1, increasing the frequency of
Fig. 5. Effects of combined bretylium and verapamil infusion. A: aconitine-induced VF was converted to VT by
bretylium, with DF of 6.6 Hz (the VT DF on immediate transition was 7.2 Hz). B: local reinjection of aconitine
increased the activation rate at aconitine site to 15.8 Hz with 2:1 conduction to the rest tissue. C: verapamil
promoted 1:1 conduction with a frequency of 14.6 Hz. D: washout returned the tissue to 2:1 conduction with
aconitine site activating at 15 Hz and the rest tissue at 7.5 Hz. PECG, DF of the pseudo-ECG; Aco, DF at the
aconitine site.
Fig. 6. Simulation of focal source VF associated with steep APD restitution [with maximum calcium channel
conductance (G si)  0.045 mS/cm2 in the Luo-Rudy model, and   1.7 and   0.7 in Eq. 2]. A, top: locations of
recording (1–3) and pacing sites (2) used to mimic the effects of aconitine (see METHODS). Bottom, APD distribution
along the x-axis during pacing at 1,000 ms. B, top: intracellular membrane potential at site 2 (“aconitine focus”)
during the transition from VT to VF (at arrow). Middle, FFT spectra for the final 2.5 s of VT (left) and the first 2.5 s
of VF (right), illustrating the sudden increase in DF peak. Bottom, FFT spectrum for the full 5 s, showing two
dominant peaks. C: FFT spectra from recording sites 1–3 during a 20-s simulation after the onset of VF, showing
broadband FFT spectra similar to those from the real heart (Fig. 4). D: two photos at time 15 s and time 15.5 s after
the onset of VF, showing multiple wavelets. Voltage decreases from red (upstroke) to green (plateau) to blue
(repolarized). E: PECG after VT-to-VF conversion.
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the aconitine focus still led to wave break due to the
APD heterogeneity in the tissue (Fig. 7, A–F). The
broken waves then formed relatively stationary spiral
waves in different domains of the tissue, with rela-
tively narrow peaks in the FFT spectra corresponding
to the intrinsic frequencies of these spiral waves. This
divided the tissue into spatially discrete, relatively
stationary domains each characterized by its own DF,
similar to the experimental findings by Samie et al.
(20). The pseudo-ECG continued to show VF (Fig. 7B,
bottom trace), unlike the experimental results with
APD restitution-flattening drugs, which converted VF
to VT. However, as in the steep APD restitution case,
once wave break occurred, maintenance of VF was not
dependent on continued excitation from the aconitine
focus, because it continued when the focus was turned
off. Thus conduction block arising from rapid firing of
the aconitine focus was essential for VF initiation, but
its maintenance depended on the intrinsic spiral wave
dynamics and not excitations from the focal source. If
Fig. 7. Focal source VF and VT with shallow APD restitution (with G si  0.07 mS/cm2, with sped-up kinetics, i.e.,
d 3 0.1 d, f 3 0.1 f). A: with the critical DI (DIc)  35 ms to simulate a relatively slow focus analogous to the
postbretylium condition in Fig. 5A, FFT spectra from recording sites 1–3 all showed a unique frequency of 10.5 Hz,
and two photos at 9.5 and 10 s show that no wave break occurred. B: on shortening DIc to 10 ms to increase pacing
rate (simulating aconitine reinjection in Fig. 5B), wave break occurred, leading to spiral wave reentry (right). FFT
spectra at sites 1–3 remained narrow, with each site showing different DFs (16.4, 15.4, and 13.8 Hz, respectively).
C: With DIc  15 ms, G si was reduced to 0.04 mS/cm2 to mimic the APD shortening effect of verapamil in Fig. 5C.
No wave break occurred (right) and FFT spectra again showed a narrow spike at 16.7 Hz. With the use of the
heterogeneity described in Eq. 3 to ensure that the “acontine focus” remains faster than intrinsic spiral wave
frequency, the results of Fig. 5, A–C, have been replicated. D: 1:1 conduction with DIc  50 ms, simulating
bretylium. E: 2:1 conduction with DIc  10 ms, simulating reinjection of aconitine. F: 1:1 conduction restored by
reducing G si to 0.04 mS/cm2 to simulate verapamil.
H1921ACONITINE VF AND RESTITUTION
AJP-Heart Circ Physiol • VOL 282 • MAY 2002 • www.ajpheart.org
APD was shortened further throughout the tissue, 1:1
conduction could be maintained without wave break
and spiral wave formation (Fig. 7C).
To reproduce the experimental findings in which
APD restitution-flattening drugs converted VF to VT
(Fig. 4) required that the aconitine focus have a higher
frequency than the intrinsic frequency of any spiral
waves in the tissue, to guarantee that the aconitine
focus would always overdrive any spiral waves. This
was achieved in the simulation by shortening the APD
locally at the aconitine focus (Fig. 7, D and E). In this
case, the rate of the aconitine focus, relative to the APD
in the surrounding tissue, determined whether the
tissue responded with 1:1 conduction (Fig. 7, D and F,
corresponding to Fig. 5, A–D) or 2:1 conduction (Fig.
7E, corresponding to Fig. 5B). In all three cases, the
pseudo-ECG showed monomorphic VT, consistent with
the experimental findings.
DISCUSSION
There are three major findings: 1) aconitine-induced
rapid focal discharges and sustained VT; 2) at baseline,
spontaneous VT-to-VF transitions occurred due to the
creation of new wave breaks; and 3) drugs that flat-
tened APD restitution converted VF back to VT, de-
spite continuous rapid activation from aconitine site.
Computer simulation studies. Computer simulations
provided further insights into the mechanisms of VF.
When electrocardiographic VF was present, VF was
maintained by the intrinsic dynamics of the spiral
waves in the tissue rather than by the aconitine focus
with fibrillatory conduction block in the surrounding
tissue. Under these conditions, APD restitution steep-
ness determined whether spatially discrete domains
with a characteristic dominant frequency were station-
ary in time. When the intrinsic frequencies of spiral
waves in the tissue were lower than the frequency of
the aconitine focus, VF invariably converted to VT,
whether conduction block was present or not. These
findings indicate that APD restitution characteristics
play a major role in determining the “phenotype” of VF.
Aconitine-induced VT-to-VF ratio. A key finding is
that with the onset of VF, DF at the aconitine site
suddenly jumped to a higher value, indicating that the
aconitine injection site was being penetrated repeat-
edly by outside wave fronts. Thus, when conduction
block at distant sites produced VF, wave breaks gen-
erated at these sites created rotors with higher fre-
quencies than the aconitine focus. Once VF was initi-
ated, the aconitine focus was no longer required for its
maintenance.
Mechanisms of VF-to-VT transition. If the focal
source hypothesis of VF is correct, two mechanisms by
which a drug might be predicted to convert VT to VF by
eliminating fibrillatory conduction block are 1) by de-
creasing the frequency of the focal source to allow 1:1
capture or 2) by decreasing the refractory period of the
tissue to allow 1:1 capture at the same focal source
frequency. Samie et al. (20) proposed that verapamil
converted VF to VT by both mechanisms. However,
Chorro et al. (2) found that DF did not correlate with
activation patterns in VF. Rather, verapamil increased
DF, whereas flecainide and sotalol diminished DF.
Despite the divergent effects, all three drugs reduced
the complexity of activation patterns in VF. Riccio et
al. (19) showed that verapamil initially increased DF
but increased VF organization in isolated canine ven-
tricles. It eventually converted VF to VT without sig-
nificantly altering DF over that during control VF.
These results are inconsistent with the DF hypothesis
(20).
An alternative mechanism to explain VF to VT tran-
sition by antiarrhythmic drugs is through flattening
APD restitution (3, 19). DAM, verapamil, and bretyl-
ium all converted aconitine-induced focal source VF to
VT, and all three drugs flatten APD restitution. In
addition, DAM and verapamil decrease APD during
both pacing and VF (11). Because decreased APD can
facilitate 1:1 conduction and might therefore convert
focal source VF to VT by eliminating fibrillatory con-
duction block, we also tested bretylium, which signifi-
cantly increases APD (3). It also converted VF to VT.
To rule out that the effects of bretylium were primarily
mediated by slowing the aconitine focus, thereby elim-
inating fibrillatory conduction block, we reinjected ac-
onitine in one experiment, which accelerated its rate
sufficiently to induce conduction block away from the
focus. Yet the rhythm remained periodic as VT, and
electrocardiographic VF did not occur. Thus, all three
APD restitution-flattening drugs converted VF to VT,
independent of their effects on APD and refractory
period. These findings support the restitution hypoth-
esis of VF.
Limitation of the study. To minimize the physiologi-
cal effects of an electromechanical uncoupler on the
patterns of activation in VF, we chose not to use an
electromechanical uncoupler during baseline VF map-
ping studies. A limitation of optical mapping study is
that cardiac contraction may result in significant mo-
tion artifact of the optical signals. This problem is most
apparent during sinus or paced rhythm, when the
ventricles contract vigorously. However, our previous
studies (9) showed that the VF CLs and patterns of
activation detected with the optical mapping system
was the same with or without the electromechanical
uncoupler cytochalasin D. These data suggest that in
the swine RV, optical mapping of VF can be performed
without the use of an electromechanical uncoupler.
We thank Ivan Velasquez, Avile McCullen, Meiling Yuan, Elaine
Lebowitz, and Scott T. Lamp for assistance.
This study was performed during the tenure of Fellowship grants
from the Save a Heart Foundation and the Israel Pacing Foundation
(to M. Swissa), College of Medicine, Yonsei University, Seoul, Korea,
and the Myung Sun Kim Memorial Foundation (both to M.-H. Lee).
This study was also supported in part by National Heart, Lung, and
Blood Institute Grants P50-HL-52319 and R01-HL-66389, American
Heart Association (AHA) National Center Grant-in-Aid 9750623N
and 9950464N, AHA National Center Scientist Development Grant
0130171N, Cedars-Sinai Electrocardiographic Heart Beat Organiza-
tion Foundation Award UC-TRDRP 9RT-0041, the Kawata and
Laubisch Endowments, a Pauline and Harold Price Endowment, and
the Ralph M. Parsons Foundation (Los Angeles, CA).
H1922 ACONITINE VF AND RESTITUTION
AJP-Heart Circ Physiol • VOL 282 • MAY 2002 • www.ajpheart.org
REFERENCES
1. Alferness C, Bayly PV, Krassowska W, Daubert JP, Smith
WM, and Ideker RE. Strength-interval curves in canine myo-
cardium at very short cycle lengths. Pacing Clin Electrophysiol
17: 876–881, 1994.
2. Chorro FJ, Canoves J, Guerrero J, Mainar L, Sanchis J,
Such L, and Lopez-Merino V. Alteration of ventricular fibril-
lation by flecainide, verapamil, and sotalol: an experimental
study. Circulation 101: 1606–1615, 2000.
3. Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee
MH, Karagueuzian HS, Weiss JN, and Chen PS. Preventing
ventricular fibrillation by flattening cardiac restitution. Proc
Natl Acad Sci USA 97: 6061–6066, 2000.
4. Jalife J, Berenfeld O, Skanes A, and Mandapati R. Mecha-
nisms of atrial fibrillation: mother rotors or multiple daughter
wavelets, or both? J Cardiovasc Electrophysiol 9: S2–S12, 1998.
5. Karma A. Electrical alternans and spiral wave breakup in
cardiac tissue. Chaos 4: 461–472, 1994.
6. KenKnight BH, Bayly PV, Gerstle RJ, Rollins DL, Wolf PD,
Smith WM, and Ideker RE. Regional capture of fibrillating
ventricular myocardium: evidence of an excitable gap. Circ Res
77: 849–855, 1995.
7. Kim YH, Garfinkel A, Ikeda T, Wu TJ, Athill CA, Weiss JN,
Karagueuzian HS, and Chen PS. Spatiotemporal complexity
of ventricular fibrillation revealed by tissue mass reduction in
isolated swine right ventricle. Further evidence for the quasi-
periodic route to chaos hypothesis. J Clin Invest 100: 2486–2500,
1997.
8. Kobayashi Y, Peters W, Khan SS, Mandel WJ, and Kara-
gueuzian HS. Cellular mechanisms of differential action poten-
tial duration restitution in canine ventricular muscle cells dur-
ing single versus double premature stimuli. Circulation 86: 955–
967, 1992.
9. Lee MH, Lin SF, Ohara T, Omichi C, Okuyama Y, Chudin
E, Garfinkel A, Weiss JN, Karagueuzian HS, and Chen PS.
Effects of diacetyl monoxime and cytochalasin D on ventricular
fibrillation in swine right ventricles. Am J Physiol Heart Circ
Physiol 280: H2689–H2696, 2001.
10. Lin SF, Abbas RA, and Wikswo JP Jr. High-resolution high-
speed synchronous epifluorescence imaging of cardiac activation.
Rev Sci Instrum 68: 213–217, 1997.
11. Liu Y, Cabo C, Salomonsz R, Delmar M, Davidenko J, and
Jalife J. Effects of diacetyl monoxime on the electrical proper-
ties of sheep and guinea pig ventricular muscle. Cardiovasc Res
27: 1991–1997, 1993.
12. Luo CH and Rudy Y. A model of the ventricular cardiac action
potential. Depolarization, repolarization, and their interaction.
Circ Res 68: 1501–1526, 1991.
13. Moe GK. On the multiple wavelet hypothesis of atrial fibrilla-
tion. Arch Int Pharmacodyn Ther 140: 183–188, 1962.
14. Moe GK and Abildskov JA. Atrial fibrillation as a self-sus-
taining arrhythmia independent of focal discharge. Am Heart J
58: 59–70, 1959.
15. Nolasco JB and Dahlen RW. A graphic method for the study
of alternation in cardiac action potentials. J Appl Physiol 25:
191–196, 1968.
16. Prinzmetal M, Corday E, Brill IC, Sellers AL, Oblath RW,
Flieg WA, and Kruger HE. Mechanism of the auricular ar-
rhythmias. Circulation 1: 241–245, 1950.
17. Qu Z, Garfinkel A, Chen PS, and Weiss JN. Mechanisms of
discordant alternans and induction of reentry in simulated car-
diac tissue. Circulation 102: 1664–1670, 2000.
18. Qu Z, Weiss JN, and Garfinkel A. Cardiac electrical restitu-
tion properties and stability of reentrant spiral waves: a simu-
lation study. Am J Physiol Heart Circ Physiol 276: H269–H283,
1999.
19. Riccio ML, Koller ML, and Gilmour RFJ. Electrical restitu-
tion and spatiotemporal organization during ventricular fibril-
lation. Circ Res 84: 955–963, 1999.
20. Samie FH, Mandapati R, Gray RA, Watanabe Y, Zuur C,
Beaumont J, and Jalife J. A mechanism of transition from
ventricular fibrillation to tachycardia: effect of calcium channel
blockade on the dynamics of rotating waves. Circ Res 86: 684–
691, 2000.
21. Voroshilovsky O, Qu Z, Lee MH, Ohara T, Fishbein GA,
Huang HL, Swerdlow CD, Lin SF, Garfinkel A, Weiss JN,
Karagueuzian HS, and Chen PS. Mechanisms of ventricular
fibrillation induction by 60-Hz alternating current in isolated
swine right ventricle. Circulation 102: 1569–1574, 2000.
22. Weiss JN, Garfinkel A, Karagueuzian HS, Qu Z, and Chen
PS. Chaos and the transition to ventricular fibrillation: a new
approach to antiarrhythmic drug evaluation. Circulation 99:
2819–2826, 1999.
23. Zaitsev AV, Berenfeld O, Mironov SF, Jalife J, and
Pertsov AM. Distribution of excitation frequencies on the epi-
cardial and endocardial surfaces of fibrillating ventricular wall
of the sheep heart. Circ Res 86: 408–417, 2000.
H1923ACONITINE VF AND RESTITUTION
AJP-Heart Circ Physiol • VOL 282 • MAY 2002 • www.ajpheart.org
